These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 25603456)

  • 61. Breast histomorphometry of rats treated with estrogen and/or progestogen.
    Torres SM; Simões RS; Baracat MC; Gomes RC; Soares Júnior JM; Carbonel AA; Baracat EC
    Rev Assoc Med Bras (1992); 2011; 57(2):177-81. PubMed ID: 21537704
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A comparative study of the effect of continuous combined conjugated equine estrogen plus medroxyprogesterone acetate and tibolone on blood coagulability.
    Skouby SO; Sidelmann JJ; Nilas L; Jespersen J
    Hum Reprod; 2007 Apr; 22(4):1186-91. PubMed ID: 17204528
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Dose-dependent changes of the ratio of apoptosis to proliferation by norethisterone and medroxyprogesterone acetate in human breast epithelial cells.
    Seeger H; Rakov V; Mueck AO
    Horm Metab Res; 2005 Aug; 37(8):468-73. PubMed ID: 16138258
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Flow resistance in carotid and middle cerebral arteries in postmenopausal women: a comparative study of tibolone and continuous combined hormone replacement therapy.
    Pan HA; Wang ST; Chen CH; Pai MC; Wu MH; Huang KE
    Climacteric; 2002 Sep; 5(3):259-65. PubMed ID: 12419084
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effects of tibolone on sulfatase pathway of estrogens metabolism and on growth of MCF-7 human breast tumors implanted in ovariectomized nude mice.
    Desreux J; Kloosterboer H; Noël A; Frankenne F; Lemaire M; Putman M; Foidart JM
    Gynecol Obstet Invest; 2007; 63(1):31-8. PubMed ID: 16899995
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Effects of estrogen and tibolone on bladder histology and estrogen receptors in rats.
    Yang X; Li YZ; Mao Z; Gu P; Shang M
    Chin Med J (Engl); 2009 Feb; 122(4):381-5. PubMed ID: 19302740
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Differential effects of conventional and low dose oral hormone therapy (HT), tibolone, and raloxifene on coagulation and fibrinolysis.
    Eilertsen AL; Sandvik L; Mowinckel MC; Andersen TO; Qvigstad E; Sandset PM
    Thromb Res; 2007; 120(3):371-9. PubMed ID: 17156824
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The hormone replacement therapy drug tibolone acts very similar to medroxyprogesterone acetate in an estrogen-and progesterone-responsive endometrial cancer cell line.
    Hanifi-Moghaddam P; Sijmons B; Ott MC; van Ijcken WF; Nowzari D; Kuhne EC; van der Spek P; Kloosterboer HJ; Burger CW; Blok LJ
    J Mol Endocrinol; 2006 Dec; 37(3):405-13. PubMed ID: 17170081
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Hormonal environment in the induction of breast cancer in castrated rats using dimethylbenzanthracene: influence of the presence or absence of ovarian activity and of treatment with estradiol, tibolone, and raloxifene.
    Callejo J; Cano A; Medina M; Villaronga M; Gonzalez-Bosquet E; Sabria J; Lailla JM
    Menopause; 2005; 12(5):601-8. PubMed ID: 16145314
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Effect on sexual life--a comparison between tibolone and continuous combined conjugated equine estrogens and medroxyprogesterone acetate.
    Uygur D; Yeşildaglar N; Erkaya S
    Gynecol Endocrinol; 2005 Apr; 20(4):209-12. PubMed ID: 16019363
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Modulation by progestogens of the effects of oestrogen on hepatic endocrine function in postmenopausal women.
    Nugent AG; Leung KC; Sullivan D; Reutens AT; Ho KK
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):690-8. PubMed ID: 14974909
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Overexpression of progesterone receptor membrane component 1: possible mechanism for increased breast cancer risk with norethisterone in hormone therapy.
    Neubauer H; Ruan X; Schneck H; Seeger H; Cahill MA; Liang Y; Mafuvadze B; Hyder SM; Fehm T; Mueck AO
    Menopause; 2013 May; 20(5):504-10. PubMed ID: 23615641
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Effects of 17beta-estradiol, progesterone, synthetic progestins, tibolone, and raloxifene on vascular endothelial growth factor and Thrombospondin-1 messenger RNA in breast cancer cells.
    Mirkin S; Wong BC; Archer DF
    Int J Gynecol Cancer; 2006; 16 Suppl 2():560-3. PubMed ID: 17010073
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Differential effects of progestogens, by type and regimen, on estrogen-metabolizing enzymes in human breast cancer cells.
    Xu B; Kitawaki J; Koshiba H; Ishihara H; Kiyomizu M; Teramoto M; Kitaoka Y; Honjo H
    Maturitas; 2007 Feb; 56(2):142-52. PubMed ID: 16962266
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The effects of estrogen and androgen on tear secretion and matrix metalloproteinase-2 expression in lacrimal glands of ovariectomized rats.
    Song X; Zhao P; Wang G; Zhao X
    Invest Ophthalmol Vis Sci; 2014 Feb; 55(2):745-51. PubMed ID: 24334444
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A 5-year study on the effect of hormone therapy, tibolone and raloxifene on vaginal bleeding and endometrial thickness.
    Christodoulakos GE; Botsis DS; Lambrinoudaki IV; Papagianni VD; Panoulis CP; Creatsa MG; Alexandrou AP; Augoulea AD; Dendrinos SG; Creatsas GC
    Maturitas; 2006 Mar; 53(4):413-23. PubMed ID: 16140483
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The effect of different preparations of hormone therapy on tumor necrosis factor-alpha levels in women with surgical menopause.
    Somunkiran A; Coskun A; Demirci F; Yucel O
    Gynecol Endocrinol; 2008 Feb; 24(2):79-83. PubMed ID: 18210330
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Estradiol valerate and tibolone: effects on memory.
    Aguiar RB; Dickel OE; Cunha RW; Monserrat JM; Barros DM; Martinez PE
    Pharmacol Biochem Behav; 2006 Dec; 85(4):689-96. PubMed ID: 17169418
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Levels of tibolone and estradiol and their nonsulfated and sulfated metabolites in serum, myometrium, and vagina of postmenopausal women following treatment for 21 days with tibolone, estradiol, or estradiol plus medroxyprogestrone acetate.
    Verheul HA; Blok LJ; Burger CW; Hanifi-Moghaddam P; Kloosterboer HJ
    Reprod Sci; 2007 Feb; 14(2):160-8. PubMed ID: 17636227
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Tibolone versus 17beta-estradiol/norethisterone: effects on the proliferation of human breast cancer cells.
    Lippert C; Seeger H; Wallwiener D; Mueck AO
    Eur J Gynaecol Oncol; 2002; 23(2):127-30. PubMed ID: 12013108
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.